Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase NA 1Phase 3 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 36Prostatic Neoplasms 27Carcinoma, Non-Small-Cell Lung 14Lymphoma 13Rectal Neoplasms 11Lung Neoplasms 11Head and Neck Neoplasms 11Recurrence 10Neoplasms 10Neoplasm Metastasis 9Carcinoma, Hepatocellular 9Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Esophageal Squamous Cell Carcinoma 8Esophageal Neoplasms 8Uterine Cervical Neoplasms 7Squamous Cell Carcinoma of Head and Neck 7Lymphoma, Non-Hodgkin 7Lymphoma, Large B-Cell, Diffuse 7Leukemia 7Central Nervous System Neoplasms 7Brain Neoplasms 7Multiple Myeloma 6Hyperthermia 6Carcinoma, Intraductal, Noninfiltrating 6Lymphoma, Follicular 5Hodgkin Disease 5Glioblastoma 5Dendritic Cell Sarcoma, Interdigitating 5Congenital Abnormalities 5Colorectal Neoplasms 5

Interventions

Transurethral Resection of Bladder 1Therapeutics 1Referral and Consultation 1Radiotherapy 1Eucalyptus Oil 1Drug Therapy 1Coal Tar 1Cisplatin 1CP protocol 1Behavior Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Paranasal Sinus Neoplasms × Radiotherapy × Clear all
NCT00347256 2008-12-10

Chemoradiotherapy Followed by Surgery for Advanced Paranasal Sinus Cancer

University of Tennessee

Phase NA Withdrawn
60 enrolled

Paranasal Sinus Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡